Inception Return
(12/23/2009)
|
5.90 %
|
|
YTD Return
|
1.33 %
|
|
NAVPS
(10/22/2018)
|
$9.33
|
|
Change
|
($0.01) / -0.10 %
|
|
|
Growth of $10,000
(As of September 30, 2018)
|
|
MER
|
2.20 %
|
|
Assets ($mil)
|
$807.96
|
|
Rank (1Yr)
|
-
|
|
Std Dev (3Yr)
|
4.37 %
|
|
Volatility Ranking (3Yr)
|
3/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Choice of Front or Back
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
6.00 %
|
|
Sales Status
|
Open
|
|
|
Objective
The Fund’s primary objective is to generate income and its secondary objective is long term capital appreciation. The Fund will seek to achieve its objective by investing directly in a diversified portfolio primarily consisting of Canadian and/or global fixed income and/or equity securities. The Fund may also indirectly invest in such securities through investments in other investment funds.
|
Management Co.
Manulife Investments
Managers
Jonathan Popper, Roshan Thiru , Richard Kos, Alan Wicks, Terry Carr, Steve Belisle, Christopher Mann, Conrad Dabiet
|
|
Asset Allocation
(As of August 31, 2018)
|
Sector Allocation
(As of August 31, 2018)
|
Geographic Allocation
(As of August 31, 2018)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Canada Government 3.50% 01-Dec-2045 | Domestic Bonds | Fixed Income | Canada | 0.00% |
| Canada Government 0.00% 13-Dec-2018 | Cash and Equivalents | Cash and Cash Equivalent | Canada | 0.00% |
| MERIT TRUST | Cash and Equivalents | Cash and Cash Equivalent | Canada | 0.00% |
| Canada Government 0.00% 10-Jan-2019 | Cash and Equivalents | Cash and Cash Equivalent | Canada | 0.00% |
| Kraft Heinz Foods Co 7.13% 01-Aug-2039 | Foreign Bonds | Fixed Income | United States | 0.00% |
| MasterCard Inc | US Equity | Financial Services | United States | 0.00% |
| Prime Sec Srvcs Borrower LLC 9.25% 15-May-2019 | Cash and Equivalents | Cash and Cash Equivalent | United States | 0.00% |
| Apple Inc | US Equity | Technology | United States | 0.00% |
| Microsoft Corp | US Equity | Technology | United States | 0.00% |
| UnitedHealth Group Inc | US Equity | Healthcare | United States | 0.00% |
Performance Data
(As of September 30, 2018)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-0.31
|
1.25
|
2.58
|
1.33
|
3.86
|
5.81
|
5.03
|
-
|
|
Benchmark
|
-1.47
|
-1.49
|
-1.24
|
2.32
|
4.86
|
3.59
|
7.78
|
6.65
|
|
Quartile Ranking
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Calendar Return (%)
|
2017
|
2016
|
2015
|
2014
|
2013
|
2012
|
2011
|
2010
|
2009
|
2008
|
|
Fund
|
7.73
|
8.61
|
-1.38
|
5.82
|
11.19
|
10.08
|
-0.70
|
9.91
|
-
|
-
|
|
Benchmark
|
3.81
|
0.39
|
16.91
|
11.35
|
10.49
|
4.94
|
5.08
|
2.36
|
-2.79
|
13.39
|
|
Quartile Ranking
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
MSCI ESG Fund Metrics (As of October 01, 2018)
|
The MSCI ESG Quality Score measures the ability of underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors.
|
|
The percentage of the portfolio's market value exposed to companies flagged for one or more standard SRI exclusion factors (alcohol, civilian firearms, gambling, weapons, cluster bombs, landmines, nuclear power, GMOs, and tobacco).
|
The portfolio weighted average of each company’s percent of revenue generated by Sustainable Impact Solutions (goods and services that address at least one of the world’s social and environmental challenges), as defined by the United Nations Sustainable Development Goals.
|
ESG data provided by MSCI
MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted to, nor received approval from, the US SEC or any other regulatory body. None of the Information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information.